The metabolomics global market report 2024 from The Business Research Company provides comprehensive market statistics, including global market size, regional shares, competitor market share, detailed segments, trends, and opportunities. This report offers an in-depth analysis of current and future industry scenarios, delivering a complete perspective for thriving in the industrial automation software market.
Metabolomics Market, 2024 report by The Business Research Company offers comprehensive insights into the current state of the market and highlights future growth opportunities.
Market Size –
The metabolomics market size has grown rapidly in recent years. It will grow from $3.11 billion in 2023 to $3.6 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to advancements in healthcare, drug discovery and development, disease biomarker identification, academic and research institutions, nutrition and food science.
The metabolomics market size is expected to see rapid growth in the next few years. It will grow to $6.68 billion in 2028 at a compound annual growth rate (CAGR) of 16.7%. The growth in the forecast period can be attributed to personalized healthcare, drug safety and efficacy, microbiome and gut health, environmental and agricultural applications, regenerative medicine. Major trends in the forecast period include integration with other omics, targeted metabolomics, single-cell metabolomics, data analytics and ai, point-of-care testing.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report
Scope Of Metabolomics Market
The Business Research Company’s reports encompass a wide range of information, including:
- Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
- Drivers: Examination of the key factors propelling market growth.
- Trends: Identification of emerging trends and patterns shaping the market landscape.
- Key Segments: Breakdown of the market into its primary segments and their respective performance.
- Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
- Macro Economic Factors: Assessment of broader economic elements impacting the market.
Metabolomics Market Overview
Market Drivers –
The increasing prevalence rate of cancer drives the metabolomics market growth. Metabolomics screens the potential biomarkers (specific cells, molecules, or genes, gene products, enzymes, or hormones) to measure the cancer drug responsiveness aiding early diagnosis. For instance, according to a report by WebMD, an American publisher of health-related news, in 2021, 10 million people died of cancer worldwide. For instance, in January 2022, according to the American Cancer Society, a US-based non-profit health organization dedicated to cancer elimination, the United States is anticipated to have 1.9 million new instances of cancer and 609,360 deaths due to cancer in 2022, for a total of 1,670 fatalities each day. Metabolomics approaches such as nuclear magnetic resonance (NMR) technique and mass spectrometry (MS) techniques have been used to study cancer. Companies like Metabolon Inc., Bruker Corp., and others have adopted metabolomics as a tool for early detection and cure for cancer.
The metabolomics market covered in this report is segmented –
1) By Product & Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools & Services
2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications
3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
Subsegments: Separation Techniques, Detection Techniques, Bioinformatics Tools and Database, Bioinformatics Services
Get an inside scoop of the metabolomics market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp
Regional Insights –
North America was the largest region in the metabolomics market in 2023. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Key Companies –
Major companies operating in the metabolomics market include Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, Kore Technologies Ltd., Dani Instruments SpA, Perkinelmer Inc., Evans Analytical Group LLC, LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Biomark Diagnostics Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Southern Research Company Inc., Alcami Corporation, Charles River Laboratories International Inc., Eremid Genomic Services LLC, Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.
Table of Contents
- Executive Summary
- Metabolomics Market Characteristics
- Metabolomics Market Trends And Strategies
- Metabolomics Market – Macro Economic Scenario
- Global Metabolomics Market Size and Growth
……………
- Key Mergers And Acquisitions In The Metabolomics Market
- Metabolomics Market Future Outlook and Potential Analysis
- Appendix
List Of Tables:
Table 1: Global Historic Market Growth, 2018-2023, $ Billion
Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
Table 3: Global Metabolomics Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 4: Global Metabolomics Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Table 5: Global Metabolomics Market, Segmentation By Metabolomics Instruments, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
…………
Table 76: Human Metabolome Technologies Inc. Financial Performance
Table 77: Metabolon Inc. Financial Performance
Table 78: Bio-Rad Laboratories Inc. Financial Performance
Table 79: Bruker Corporation Financial Performance
Table 80: Agilent Technologies Inc Financial Performance
Read Related Reports:
https://goodprnews.com/electrosurgical-devices-and-equipment-market-size/
https://topprnews.com/coal-lignite-and-anthracite-market-overview/
Learn About Us:
The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
